(Corrects spelling of place in dateline to CHHINDWARA not CHHINDHWARA) By Rishika Sadam CHHINDWARA, India (Reuters) -Indian police have arrested the owner of Sresan Pharmaceutical Manufacturer, the cough syrup company linked to the deaths of at least 19 children in the central state of Madhya Pradesh, a senior police officer told Reuters on Thursday. The […]
Health
Indian police arrest owner of cough syrup company linked to deaths of 19 children
Audio By Carbonatix
(Corrects spelling of place in dateline to CHHINDWARA not CHHINDHWARA)
By Rishika Sadam
CHHINDWARA, India (Reuters) -Indian police have arrested the owner of Sresan Pharmaceutical Manufacturer, the cough syrup company linked to the deaths of at least 19 children in the central state of Madhya Pradesh, a senior police officer told Reuters on Thursday.
The children, all under five years of age, died in the past month in the state’s Chhindwara city, after consuming cough medicine containing toxic diethylene glycol in quantities nearly 500 times the permissible limit.
The deaths were all linked to Sresan Pharma’s Coldrif syrup, which has been banned in several parts of India after a test confirmed the presence of the chemical last Thursday.
SYRUP FACTORY OWNER ARRESTED
S.Ranganathan, owner of the Tamil Nadu state-based company that manufactured the syrup, was arrested on Wednesday in Chennai where he will appear in court before being moved to Chhindwara, Chhindwara Superintendent of Police Ajay Pandey told Reuters.
Local drug authorities have stepped up efforts to curb the circulation of contaminated medicine, testing random samples of cough syrups and making door-to-door calls to retrieve Coldrif bottles,
“We (have) got 30-40 bottles (through this means)…we (also) recalled some from retailers and stockists,” district administrator Harendra Narayan said, adding that 594 bottles of the syrup were sold to pharmaceutical stockists in the region over the last six weeks.
By law, Indian drugmakers must test each batch of raw materials and the final product.
Exports of cough syrup require another layer of tests at government-mandated laboratories since 2023, after the deaths of over 10 children in Gambia, Uzbekistan and Cameroon were linked to Indian syrups.
The World Health Organization has said the recent case highlights a “regulatory gap” in India’s screening of medicines being sold domestically, and warned that some exports could have been made unofficially.
Indian authorities have asked people to avoid two other locally-sold syrups, Respifresh and RELIFE, made by Gujarat state-based Shape Pharma and Rednex Pharmaceuticals, after tests found they contained the same toxic chemical.Known as the “pharmacy of the world”, India is the third-largest drug producer by volume after the U.S. and China.
The country supplies 40% of generic medicines used in the U.S., and more than 90% of all medicines in many African nations.
(Reporting by Rishika Sadam; Writing by Sakshi Dayal and Surbhi Misra; Editing by Jamie Freed and Ed Osmond)